Stegmann AP - Search Results

1

Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors.

Pallard C, Stegmann AP, van Kleffens T, Smart F, Venkitaraman A, Spits H. Pallard C, et al. Among authors: stegmann ap. Immunity. 1999 May;10(5):525-35. doi: 10.1016/s1074-7613(00)80052-7. Immunity. 1999. PMID: 10367898 Free article.

2

Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3.

Heemskerk MH, Blom B, Nolan G, Stegmann AP, Bakker AQ, Weijer K, Res PC, Spits H. Heemskerk MH, et al. Among authors: stegmann ap. J Exp Med. 1997 Nov 3;186(9):1597-602. doi: 10.1084/jem.186.9.1597. J Exp Med. 1997. PMID: 9348318 Free PMC article.

3

Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.

Blom B, Heemskerk MH, Verschuren MC, van Dongen JJ, Stegmann AP, Bakker AQ, Couwenberg F, Res PC, Spits H. Blom B, et al. Among authors: stegmann ap. EMBO J. 1999 May 17;18(10):2793-802. doi: 10.1093/emboj/18.10.2793. EMBO J. 1999. PMID: 10329625 Free PMC article.

4

Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3.

Jaleco AC, Stegmann AP, Heemskerk MH, Couwenberg F, Bakker AQ, Weijer K, Spits H. Jaleco AC, et al. Among authors: stegmann ap. Blood. 1999 Oct 15;94(8):2637-46. Blood. 1999. PMID: 10515867 Free article.

5

Transfection of wild-type deoxycytidine kinase (dck) cDNA into an AraC- and DAC-resistant rat leukemic cell line of clonal origin fully restores drug sensitivity.

Stegmann AP, Honders WH, Willemze R, Ruiz van Haperen VW, Landegent JE. Stegmann AP, et al. Blood. 1995 Mar 1;85(5):1188-94. Blood. 1995. PMID: 7532033 Free article.

6

Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.

Ruiz van Haperen VW, Veerman G, Eriksson S, Boven E, Stegmann AP, Hermsen M, Vermorken JB, Pinedo HM, Peters GJ. Ruiz van Haperen VW, et al. Among authors: stegmann ap. Cancer Res. 1994 Aug 1;54(15):4138-43. Cancer Res. 1994. PMID: 8033147

7

Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.

Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ. Ruiz van Haperen VW, et al. Among authors: stegmann ap. Semin Oncol. 1995 Aug;22(4 Suppl 11):35-41. Semin Oncol. 1995. PMID: 7481843

8

Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells.

Brooimans RA, Stegmann AP, van Dorp WT, van der Ark AA, van der Woude FJ, van Es LA, Daha MR. Brooimans RA, et al. Among authors: stegmann ap. J Clin Invest. 1991 Aug;88(2):379-84. doi: 10.1172/JCI115314. J Clin Invest. 1991. PMID: 1864952 Free PMC article.

9

Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation.

Welters MJ, Oei FB, Vaessen LM, Stegmann AP, Bogers AJ, Weimar W. Welters MJ, et al. Among authors: stegmann ap. Clin Exp Immunol. 2001 Jun;124(3):353-8. doi: 10.1046/j.1365-2249.2001.01557.x. Clin Exp Immunol. 2001. PMID: 11472394 Free PMC article.

10

In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase (dck) gene.

Stegmann AP, Honders MW, Hagemeijer A, Hoebee B, Willemze R, Landegent JE. Stegmann AP, et al. Ann Hematol. 1995 Jul;71(1):41-7. doi: 10.1007/BF01696231. Ann Hematol. 1995. PMID: 7543292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters